Publication | Closed Access

Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?

Tsh SuppressionFirst Disease AssessmentMedicineThyroid DiseaseThyroid HormoneOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences